Volume 66 Received 16 November 2009 | ||||||||||
| ||||||||||
aThe College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, People's Republic of China
Correspondence e-mail: shihao@zjut.edu.cn
The title compound, C22H34O3, was synthesized from isosteviol. The asymmetric unit contains of two independent molecules with the same absolute configurations. In both the molecules, the three six-membered rings adopt chair conformations, the stereochemistry of the A/B and B/C ring junctions are trans, and the five-membered ring D adopts an envelope conformation.
Since the title compound was prepared from isosteviol, the configuration can be deduced from the known chirality of the isosteviol, see: Rodrigues & Lechat (1988
), Xue et al. (1993
). For the pharmacological activity of isosteviol, see: Liu et al. (2001
); Mizushina et al. (2005
); Wong et al. (2004
); Zhang & Xu (2004
). For ring conformations, see: Cremer & Pople (1975
).
|
|
|
Data collection: SMART (Bruker, 1999
); cell refinement: SAINT (Bruker, 1999
); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: ORTEP-3 (Farrugia, 1997
); software used to prepare material for publication: SHELXL97 nd PLATON (Spek, 2009
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: DN2514 ).
This material is based upon work funded by the Zhejiang Provincial Natural Science Foundation of China under grant No. Y2090552 and the Open Foundation of Key Disciplines within the Zhejiang Provincial Key Disciplines.
Bruker (1999). SMART, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.
![[ISI]](../../../../../../logos/isiborder.gif)
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
![[details]](../../../../../../j/graphics/details.gif)
Liu, J. C., Kao, P. F., Hsieh, M. H., Chen, Y. J. & Chan, P. (2001). Acta Cardiol. Sin. 17, 133-140.
Mizushina, Y., Akihis, T., Ukiya, M., Hamasaki, Y., Murakami-Nakai, C., Kuriyama, I., Takeuchi, T., Sugawara, F. & Yoshid, H. (2005). Life Sci. 77, 2127-2140.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Rodrigues, A. M. G. D. & Lechat, J. R. (1988). Acta Cryst. C44, 1963-1965.
![[details]](../../../../../../c/graphics/details.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)
Wong, K. L., Chan, P., Yang, H. Y., Hsu, F. L., Liu, I. M., Cheng, Y. W. & Cheng, J. T. (2004). Life Sci. 74, 2379-2387.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Xue, J. Y., Tang, S. X., Cao, Y. R., Wang, X. L., Wang, R. J., Wang, H. G. & Lu, X. J. (1993). Chem. Res. Chin. Univ. 9, 201-207. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Zhang, S. J. & Xu, D. Y. (2004). Chin. J. Pharmacol. Toxicol. 18, 427-432.